We are pleased to announce the appointment of Bianca Matthee as our VP of Research Operations.
Ms. Matthee brings nearly 20 years of experience in the operational realization of corporate strategy in biotech/pharma. She has filled line- and program leadership positions in businesses of various sizes and has advised multiple biotech firms as an independent consultant. Before joining Tagworks, she was COO at Hybridize Therapeutics, VP Manufacturing & Pharmaceutics at ProQR and she held positions in R&D at CureVac (Frame), Johnson & Johnson (Crucell) and Merck, Sharp & Dome (Organon, Schering Plough).

The expertise of Ms. Matthee supports the ambition of Tagworks Pharmaceuticals to grow and to change the standard of care for patients suffering from severe diseases including cancer by building a pipeline of first-in-class Click-to-Release therapeutics.

We feel privileged to welcome Bianca to our company !